The progression of OSF toward malignancy is associated with the upregulation of SPARC, activation of MMP9, and overexpression of ITGA5, promoting ECM degradation, facilitating cell invasion, and driving tumor progression. The gene discussed is SPARC; the disease is neoplasm.